Connor, Clark & Lunn Investment Management (CC&L)’s Nuvation Bio NUVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-422,260
| Closed | -$1.12M | – | 1543 |
|
|
2024
Q4 | $1.12M | Buy |
422,260
+25,524
| +6% | +$67.9K | 0.01% | 892 |
|
|
2024
Q3 | $909K | Buy |
396,736
+32,811
| +9% | +$75.1K | ﹤0.01% | 911 |
|
|
2024
Q2 | $1.06M | Sell |
363,925
-18,255
| -5% | -$53.3K | ﹤0.01% | 832 |
|
|
2024
Q1 | $1.39M | Buy |
382,180
+88,477
| +30% | +$322K | 0.01% | 786 |
|
|
2023
Q4 | $443K | Buy |
293,703
+17,529
| +6% | +$26.5K | ﹤0.01% | 1075 |
|
|
2023
Q3 | $370K | Buy |
276,174
+112,891
| +69% | +$151K | ﹤0.01% | 1093 |
|
|
2023
Q2 | $294K | Buy |
163,283
+107,238
| +191% | +$193K | ﹤0.01% | 1111 |
|
|
2023
Q1 | $93K | Sell |
56,045
-10,669
| -16% | -$17.7K | ﹤0.01% | 1159 |
|
|
2022
Q4 | $128K | Buy |
+66,714
| New | +$128K | ﹤0.01% | 1096 |
|